According to the research report, the global biosimulation market size is expected to touch USD 9.17 Billion by 2030, from USD 3.12 Billion in 2022, growing with a significant CAGR of 14.4% from 2022 to 2030.
The biosimulation report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global biosimulation in conjunction with
the geographical landscape of this vertical have also been included in this
report.
The report offers intricate dynamics about
different aspects of the global biosimulation market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global biosimulation during the forecast period. It also includes
a key indicator assessment that highlights growth prospects of this market and
estimates statistics related to growth of the market in terms of value (US$ Mn)
and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1646
| Report Coverage | Details |
| Market Size by 2030 | USD 9.17 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 14.4% |
| Packaging Segment Market Share in 2021 | 46% |
| Software Segment Makret Share in 2021 | 66% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End User, Delivery Model, Geography |
This study covers a detailed segmentation
of the global biosimulation market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global biosimulation market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Biovia
- Certara
- Compugen Inc.
- Genedata
- In Silico Biosciences, Inc.
- Leadscope Inc.
- Pharmaceutical Product Development, LLC.
- Schrödinger, LLC.
- Simulations Plus, Inc.
- DassaultSystemes
- Advanced Chemistry Development
Market Segmentation
- Software
- Services
- Contract Services
- In-House Services
By Application
- Drug Discovery
- Lead Identification
- Lead Optimization
- Target Identification
- Target Validation
- Drug Development
- Preclinical Testing and Clinical Trials
- In Patient Validation
- Others
By End User
- Regulatory Authorities
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
By Delivery Model
- Subscription Models
- Ownership Models
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global biosimulation report is based on detailed
primary as well as secondary research. With the help of in-depth insights of
the market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and authentic
forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global biosimulation market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biosimulation Market
5.1. COVID-19 Landscape: Biosimulation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biosimulation Market, By Product
8.1. Biosimulation Market, by Product Type, 2022-2030
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Biosimulation Market, By Application
9.1. Biosimulation Market, by Application, 2022-2030
9.1.1. Drug Discovery
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Drug Development
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Biosimulation Market, By End User Type
10.1. Biosimulation Market, by End User Type, 2022-2030
10.1.1. Regulatory Authorities
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Pharmaceutical & Biotechnology Companies
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Contract Research Organizations (CROs)
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Academic Research Institutes
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Biosimulation Market, By Delivery Model Type
11.1. Biosimulation Market, by Delivery Model Type, 2022-2030
11.1.1. Subscription Models
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Ownership Models
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Biosimulation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Delivery Model Type (2017-2030)
Chapter 13. Company Profiles
13.1. Biovia
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Certara
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Compugen Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Genedata
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. In Silico Biosciences, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Leadscope Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pharmaceutical Product Development, LLC.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Schrödinger, LLC.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Simulations Plus, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. DassaultSystemes
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments